Safety of different inter-train intervals for repetitive transcranial magnetic stimulation and recommendations for safe ranges of stimulation parameters

Electroencephalography and Clinical Neurophysiology
R ChenL G Cohen

Abstract

Induction of a seizure in a normal subject with trains of repetitive transcranial magnetic stimulation (rTMS) applied in close succession suggested that short inter-train intervals, a parameter not considered in our previous safety studies, may not be safe. Here, we evaluate the safety of different inter-train intervals for rTMS in 10 healthy volunteers. Ten rTMS trains at 20 Hz for 1.6 s and a stimulus intensity of 110% of motor threshold (MT) were found to be safe at the inter-train interval of 5 s. However, inter-train intervals of 1 s or less were unsafe for trains of 20 Hz for 1.6 s and stimulus intensities higher than 100% of MT. Based on these results, we propose safety guidelines for inter-train intervals at different stimulus intensities. We also analyzed the stimulus parameters, used in 3 studies, that led to seizures in normal subjects. One seizure was due to short inter-train intervals, one was likely related to intense individual rTMS trains close to the limit of our previous safety recommendations, and one was likely due to a combination of these two factors. To provide an additional safety margin, we suggest reducing the duration for individual rTMS trains by 25% from our previous recommendations. Updated safety ...Continue Reading

Citations

May 20, 2006·Experimental Brain Research·Demis BassoNiels Birbaumer
Mar 23, 2011·Experimental Brain Research·Norman Holl, Volker Zschorlich
Nov 30, 2010·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Roger J PaxtonChristopher Bell
May 27, 2003·Journal of Psychiatric Research·Uwe HerwigCarlos Schönfeldt-Lecuona
Sep 23, 2003·Brain Research. Brain Research Reviews·Alexander T Sack, David E J Linden
Dec 14, 2002·Brain and Cognition·Sulekha Anand, John Hotson
Apr 29, 1998·Epilepsy Research·U ZiemannW Paulus
Aug 30, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H Jing, M Takigawa
Feb 13, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H JingH Fukuzako
Jun 29, 2002·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Paul B FitzgeraldJ Kulkarni
May 10, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Carlo Alberto TassinariRoberto Michelucci
Jul 13, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·C M EpsteinK R Davey
Apr 12, 2002·Acta Psychiatrica Scandinavica·P B FitzgeraldZ J Daskalakis
Jul 17, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mera S BarrZafiris J Daskalakis
Oct 24, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Tim V SalomonsJonathan Downar
Mar 31, 2010·Proceedings of the National Academy of Sciences of the United States of America·Liane YoungRebecca Saxe
Oct 24, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·H OkamuraM Takigawa
Dec 13, 2002·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·David B MacDonald
Jun 22, 2011·The Journal of Head Trauma Rehabilitation·Asli Demirtas-TatlidedeAlvaro Pascual-Leone
Oct 7, 2009·Journal of Cognitive Neuroscience·Martijn Gerbrand van KoningsbruggenRobert D Rafal
Jan 1, 2011·European Journal of Psychotraumatology·Vladan NovakovicRachel Yehuda
May 15, 2013·Brain Stimulation·F Andrew KozelKimberly S Mapes
Sep 25, 2012·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Crystal L MassieMatthew P Malcolm
Jul 20, 2012·Brain Stimulation·Victoria C WingTony P George
Mar 17, 2009·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·David H BenningerMark Hallett
Aug 8, 2014·Cerebral Cortex·Robin F H CashUlf Ziemann
Apr 9, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Eun Yeon JooSeung Bong Hong
Nov 6, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Masashi HamadaYoshikazu Ugawa
Sep 18, 2009·Developmental Medicine and Child Neurology·George F Wittenberg
Mar 26, 2003·The European Journal of Neuroscience·Wolfgang KlimeschChristian Gerloff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.